Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP

Answer the questions:

1. What are the 10 biggest for-profit companies in this field?
   • How is the market distributed?
   • Where are they located? Are there any incentives for specific locations?
   • Correlate them with their main outputs (Data. Narratives. Tools)
   • Understand and identify cases where these companies are “experimenting” or “adopting” commons-based approaches
   • Identify these cases and treat them as entities that will also be placed in our mapping*device (the quadrants)
   • Identify what companies are the “Microsofts” of the field and what companies are the “IBMs” of the field

<colgroup><col width="138"/><col width="148"/><col width="191"/><col width="273"/><col width="130"/><col width="251"/><col width="99"/></colgroup>

	2006 Revenue ($m)	Headquarters	Primary Outputs	Instances of Commons-based approaches	Sources
Amgen	14268	Thousand Oaks, California	ten approved drugs for 15 conditions, 23 agents are being tested earlier in the approval pipeline	?	http://en.wikipedia.org/wiki/Amgen
Genentech	9284	South San Francisco	synthetic human insulin - their first famous product, many others produced using the Boyer-Cohen rDNA process	?	http://en.wikipedia.org/wiki/Genentech
Genzyme	3187	Cambridge, Massachusetts	Cerezyme (treats Gaucher's disease) accounts for 30% of company's revenue	?	http://en.wikipedia.org/wiki/Genzyme
Gilead Sciences	3026	Foster City, California	11 commerical products	?	http://en.wikipedia.org/wiki/Gilead_Sciences
Biogen Idec	2683	Cambridge, Massachusetts	Treatments for Crohn's disease, non-Hodgkin's lymphoma, and multiple sclerosis	?	http://en.wikipedia.org/wiki/Biogen_Idec
Cephalon	1764	Frazer, Pennsylvania	Specializes in treating neurodegenerative diseases	?	http://en.wikipedia.org/wiki/Cephalon
MedImmune	1277	Gaithersburg, Maryland	Only major drug prevents respiratory diseases in infants	?	<a href="http://en.wikipedia.org/wiki/MedImmune">http://en.wikipedia.org/wiki/MedImmune</a>
Celgene	899	Summit, New Jersey	treatments for erythema nodosum leprosum ("ENL") and multiple myeloma	?	http://en.wikipedia.org/wiki/Celgene
Abraxis BioScience	766	Los Angeles, California	uses patented nanoparticle technology to produce products for metastatic breast cancer	?
ImClone Systems	678	New York, New York	acquired by Eli Lilly, tried to produce Erbitux for Colorectal Cancer, but failed to win FDA approval	?	http://en.wikipedia.org/wiki/ImClone_Systems
Note on outputs: all these companies make their money primarily through developing and patenting drugs. The distinguishing factor seems to be that the largest of these companies produce the drugs themselves, while the smaller ones license these drugs to be produced by larger pharmaceutical companies
http://en.wikipedia.org/wiki/List_of_biotechnology_companies

<colgroup><col width="99"/></colgroup><colgroup><col width="99"/></colgroup>